C. Peschel

Informatics and Medicine

H. Mewes, N. Navab, E. Mayr, 2008, Methods of Information in Medicine.

Individualized neoadjuvant treatment strategy in adenocarcinoma of the esophago-gastric junction (AEG): Interim report on the MUNICON trial.

M. Schwaiger, F. Lordick, J. Siewert, 2004, Journal of Clinical Oncology.

Prospective multicentre randomized double-blind placebo-controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections

C. Peschel, W. Vahlensieck, A. Neisius, 2022, International Urology and Nephrology.

Die Differentialdiagnose der primären Knochenmarkinsuffizienz

C. Peschel, H. Denz, P. Pohl, 1983 .

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron.

R. Labianca, A. Macciocchi, M. Aapro, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant therapy for oesophagogastric cancer

F. Lordick, C. Peschel, C. Peschel, 2004, The British journal of surgery.

Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma.

F. Lordick, C. Peschel, C. Peschel, 2006, Endoscopy.

[Antiemetic prophylaxis in the chemotherapy of gastrointestinal tumours].

F. Lordick, C. Peschel, A. Ihbe-Heffinger, 2005, Zeitschrift für Gastroenterologie - German Journal of Gastroenterology.